We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
334 hedge funds and large institutions have $4.44B invested in Acadia Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 120 increasing their positions, 119 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more call options, than puts
Call options by funds: $7.66M | Put options by funds: $5.68M
24% more capital invested
Capital invested by funds: $3.58B → $4.44B (+$863M)
21% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 43
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
1% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 119
0% more funds holding
Funds holding: 333 → 334 (+1)
1.06% less ownership
Funds ownership: 99.39% → 98.33% (-1.1%)
Holders
334
Holders Change
+1
Holders Change %
+0.3%
% of All Funds
4.06%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.07%
New
52
Increased
120
Reduced
119
Closed
43
Calls
$7.66M
Puts
$5.68M
Net Calls
+$1.97M
Net Calls Change
-$6.13M
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$59.1M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$44.6M |
| 3 |
Citigroup
New York
|
-$35.6M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$28.7M |
| 5 |
Millennium Management
New York
|
-$22.2M |